IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BAREI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.219
NA - Nord America 804
EU - Europa 471
SA - Sud America 114
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.637
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 763
SG - Singapore 391
CN - Cina 374
IT - Italia 150
VN - Vietnam 138
BD - Bangladesh 91
BR - Brasile 91
HK - Hong Kong 74
DE - Germania 64
RU - Federazione Russa 60
FR - Francia 47
IN - India 45
NL - Olanda 30
GB - Regno Unito 28
CA - Canada 27
FI - Finlandia 26
KR - Corea 23
ES - Italia 18
CI - Costa d'Avorio 17
ID - Indonesia 15
JP - Giappone 15
TR - Turchia 14
PL - Polonia 13
AR - Argentina 10
MX - Messico 9
SE - Svezia 9
ZA - Sudafrica 6
CO - Colombia 5
JO - Giordania 5
AT - Austria 4
IE - Irlanda 4
IL - Israele 4
IQ - Iraq 4
PH - Filippine 4
PK - Pakistan 4
MA - Marocco 3
PT - Portogallo 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
IR - Iran 2
NO - Norvegia 2
NP - Nepal 2
RO - Romania 2
TW - Taiwan 2
UA - Ucraina 2
UZ - Uzbekistan 2
VE - Venezuela 2
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
GR - Grecia 1
HT - Haiti 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MW - Malawi 1
MY - Malesia 1
NI - Nicaragua 1
PS - Palestinian Territory 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.637
Salva come PNG Salva come JPEG
Città #
Ashburn 166
Singapore 152
Hefei 118
Los Angeles 56
Dallas 53
Milan 52
Beijing 48
Hong Kong 47
San Jose 46
Council Bluffs 45
Ho Chi Minh City 43
Hanoi 38
Santa Clara 38
Frankfurt am Main 29
Lauterbourg 29
Bengaluru 26
Munich 20
New York 20
Helsinki 19
Seoul 19
Boardman 18
Abidjan 17
Denver 17
Moscow 16
Montreal 14
Buffalo 13
Guangzhou 13
Jakarta 12
Chicago 11
Atlanta 10
Tokyo 10
Warsaw 10
Haiphong 9
Orem 9
Shanghai 9
Istanbul 8
São Paulo 8
Phoenix 7
Rome 7
Turin 7
Chennai 6
Da Nang 6
Houston 6
Manaus 6
Shenzhen 6
Amman 5
Chandler 5
Johannesburg 5
London 5
Madrid 5
Memphis 5
Nuremberg 5
Washington 5
Amsterdam 4
Ankara 4
Bologna 4
City of London 4
Dublin 4
Düsseldorf 4
Lappeenranta 4
Miami 4
Shijiazhuang 4
Toronto 4
Berlin 3
Biên Hòa 3
Boston 3
Brasília 3
Brooklyn 3
Cangzhou 3
Casoria 3
Congonhas 3
Florence 3
Freiburg im Breisgau 3
Genoa 3
Gravatá do Ibiapina 3
Lanzhou 3
Manchester 3
Mumbai 3
New Delhi 3
Poplar 3
Providence 3
Salt Lake City 3
San Francisco 3
Santo André 3
Seattle 3
Suzhou 3
Thái Bình 3
Turku 3
Yongin-si 3
Zhengzhou 3
Belo Horizonte 2
Binzhou 2
Bogotá 2
Bucharest 2
Bến Tre 2
Campinas 2
Campolongo Maggiore 2
Can Tho 2
Charlotte 2
Chongqing 2
Totale 1.500
Salva come PNG Salva come JPEG
Nome #
Omalizumab for the Treatment of Chronic Spontaneous Urticaria in Adults and Adolescents: An Eight-Year Real-Life Experience 194
Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors 158
Five cases of new-onset pemphigus following vaccinations against coronavirus disease 2019 151
Ulcerative injection site reaction after third COVID-19 vaccine dose with mRNA-1273 147
Long-term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: a 3-year real-life study 136
Does body mass index impact the clinical response to dupilumab therapy in atopic dermatitis? A monocentric study of 170 patients 135
Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitors 121
A case of Grover disease treated with Dupilumab: Just serendipity or a future perspective? 114
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study 111
Severe Allergic Contact Dermatitis to Hair Dye in a Patient With Atopic Dermatitis During Dupilumab Therapy 105
Abrupt Bullous Cutaneous Eruption After Application of Tacrolimus Ointment and Sun Exposure 104
Successful treatment of prurigo nodularis with upadacitinib 103
Special sites in atopic dermatitis: Effectiveness of dupilumab on the hands in a single‐centre study on 485 patients 101
Efficacy and Drug Survival of Tralokinumab in Severe Atopic Dermatitis: An 18-Month Multicenter Experience 100
Effectiveness of dupilumab in tralokinumab-resistant patients with atopic dermatitis: A real-world experience from two referral centres 95
Effectiveness of dupilumab in atopic dermatitis on the head and neck: a single-center study on 553 patients 89
Reply to “New-onset bullous pemphigoid after inactivated Covid-19 vaccine: Synergistic effect of the Covid-19 vaccine and vildagliptin” 87
Assessment of patient-reported outcomes at 24 weeks of treatment with tralokinumab for atopic dermatitis: a multicentric real-life experience 85
Effectiveness of Tralokinumab Across Atopic Dermatitis Phenotypes 83
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study 79
Three-year observational study on the ​long-term efficacy and safety of dupilumab in elderly patients with severe atopic dermatitis 79
Dermoscopic features of dermal duct tumors 74
Dupilumab: a new frontier for chronic urticaria. A case series and review of the literature 71
Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areata 70
Effectiveness of Dupilumab and Tralokinumab in Treating Nummular Eczema 38
Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis 37
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study 33
Patch Testing Under Biologics: Six Cases From a Tertiary Centre 26
Cutaneous angiosarcoma of the head: a case from Italy 24
Phenotypic Switch From Atopic Dermatitis to Psoriasis During Dupilumab Therapy: A Real-Life Experience From a Tertiary Referral Center 8
Effectiveness of Tralokinumab for Moderate-to-Severe Atopic Dermatitis Involving the Head-and-Neck Area: A Multicenter Retrospective Cohort Study 8
Letter: Tralokinumab Dose Spacing in Moderate-to-Severe Atopic Dermatitis: A Real-World Case Series 3
Patch test sensitization and permanent tattoos: epidemiological data from two referral centers 1
Totale 2.770
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.304
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222 0 0 0 0 0 0 0 0 0 0 2 0
2022/202346 0 0 0 8 6 4 1 6 8 3 7 3
2023/202492 1 9 5 7 24 5 7 7 2 7 9 9
2024/2025394 2 31 13 16 26 18 27 21 32 34 41 133
2025/20262.236 236 255 260 293 241 102 207 74 153 134 181 100
Totale 2.770